Stephen David Prior, Chief Strategy Officer at AN2 Therapeutics, Inc. (ANTX), sold 6,462 shares at $1.00 ($6K) on 2026-01-05, disclosed to the SEC on 2026-01-07.
Open-market sale of $6k ANTX by Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.00 | 3,604 | $4K | 55.5% |
| 2 | $1.01 | 2,858 | $3K | 44.5% |
| Total | $1.00 avg | 6,462 | $6K | 100% |
| Filing → |